PDLIM7 and lymphoma: Using this model, we discovered that an LMP1-deleted EBV mutant causes activated DLBCLs in vivo because CD40L-expressing CD4 T cells in the tumor microenvironment can substitute for LMP1 [43] in lymphomas with type III latency that express EBNA2.